Colgate-Palmolive Company $CL Stock: Investment House LLC Trims Holdings

Investment House LLC trimmed its holdings in Colgate-Palmolive Company (NYSE:CL) by 71.5% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 2,710 shares of the company’s stock after selling 6,813 shares during the quarter. Investment House LLC’s holdings in Colgate-Palmolive were worth $231,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Cooper Financial Group raised its stake in Colgate-Palmolive by 4.0% during the 2nd quarter. Cooper Financial Group now owns 2,947 shares of the company’s stock valued at $270,000 after acquiring an additional 114 shares in the last quarter. Gould Capital LLC boosted its position in Colgate-Palmolive by 38.7% during the 1st quarter. Gould Capital LLC now owns 412 shares of the company’s stock worth $35,000 after acquiring an additional 115 shares during the period. Redhawk Wealth Advisors Inc. boosted its position in Colgate-Palmolive by 2.8% during the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 4,326 shares of the company’s stock worth $397,000 after acquiring an additional 118 shares during the period. SVB Wealth LLC grew its stake in shares of Colgate-Palmolive by 1.4% in the second quarter. SVB Wealth LLC now owns 8,767 shares of the company’s stock worth $804,000 after purchasing an additional 119 shares in the last quarter. Finally, Sowell Financial Services LLC grew its stake in shares of Colgate-Palmolive by 2.1% in the third quarter. Sowell Financial Services LLC now owns 5,737 shares of the company’s stock worth $490,000 after purchasing an additional 119 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Colgate-Palmolive

In related news, Director John Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $93.37, for a total transaction of $389,352.90. Following the transaction, the director directly owned 28,373 shares of the company’s stock, valued at $2,649,187.01. The trade was a 12.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Noel Wallace sold 161,021 shares of the business’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the sale, the chief executive officer owned 362,231 shares in the company, valued at approximately $33,296,273.52. This trade represents a 30.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 175,191 shares of company stock valued at $16,110,903 over the last 90 days. 0.43% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on CL. Jefferies Financial Group reissued a “hold” rating and set a $89.00 price target (up from $88.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Bank of America reduced their price objective on shares of Colgate-Palmolive from $102.00 to $100.00 and set a “buy” rating for the company in a report on Friday, October 9th. TD Cowen increased their target price on shares of Colgate-Palmolive from $85.00 to $90.00 and gave the company a “hold” rating in a research report on Monday, August 3rd. Piper Sandler lowered their target price on shares of Colgate-Palmolive from $98.00 to $95.00 and set an “overweight” rating on the stock in a research note on Monday, September 21st. Finally, Evercore boosted their price target on shares of Colgate-Palmolive from $100.00 to $101.00 and gave the stock an “outperform” rating in a research report on Thursday, October 8th. Thirteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $98.00.

Key Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Analysts expect earnings growth, and Zacks says Colgate-Palmolive has a favorable combination of earnings estimates and historical earnings surprises that could support a quarterly beat. Colgate-Palmolive earnings expectations
• Positive Sentiment: Recent coverage has highlighted strong toothpaste performance, while Colgate-Palmolive India reported 12.2% revenue growth, 4.3% profit growth and modest gross-margin expansion. These results may offer some support for the broader brand portfolio, although the Indian subsidiary is not the same entity as the U.S.-listed parent. Colgate-Palmolive India quarterly results
• Neutral Sentiment: Options activity was elevated, with investors purchasing 4,443 put contracts—about 71% above typical volume—signaling increased hedging or bearish positioning ahead of the report, but not necessarily confirming a change in fundamentals.
• Neutral Sentiment: Institutional positioning was mixed in the latest quarter: 851 investors added shares while 853 reduced holdings. Analyst targets remain varied, with a reported median of $96, suggesting limited upside relative to recent trading levels.
• Negative Sentiment: Investors remain concerned about raw-material and packaging inflation, tariff effects, intense category competition and pressure on consumer spending. Management has also warned that volatile market conditions could persist through the rest of 2026. Colgate-Palmolive defensive rally and earnings risks
• Negative Sentiment: Insiders have reported five open-market sales and no purchases over the past six months, including substantial sales by CEO Noel Wallace. While insider transactions can reflect personal financial decisions, the lack of buying may weigh on sentiment.

Colgate-Palmolive Stock Performance

CL opened at $94.10 on Friday. The business has a 50 day moving average price of $89.26 and a two-hundred day moving average price of $89.35. The company has a debt-to-equity ratio of 13.82, a current ratio of 1.03 and a quick ratio of 0.67. The company has a market capitalization of $75.02 billion, a price-to-earnings ratio of 37.34, a price-to-earnings-growth ratio of 4.71 and a beta of 0.33. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%. The company had revenue of $5.36 billion for the quarter, compared to analysts’ expectations of $5.36 billion. During the same period last year, the firm earned $0.92 EPS. The firm’s revenue for the quarter was up 4.9% on a year-over-year basis. Research analysts predict that Colgate-Palmolive Company will post 3.87 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Tuesday, October 20th will be paid a dividend of $0.53 per share. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 annualized dividend and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 84.13%.

About Colgate-Palmolive

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.